Combatting Substandard and Falsified Medicines: A View from Rwanda

article has not abstract

Vyšlo v časopise: Combatting Substandard and Falsified Medicines: A View from Rwanda. PLoS Med 10(7): e32767. doi:10.1371/journal.pmed.1001476
Kategorie: Essay
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001476

Souhrn

article has not abstract

Zdroje

1. Institute of Medicine (2013) Countering the problem of falsified and substandard drugs. Washington (District of Columbia): The National Academies Press. Available: http://www.iom.edu/Reports/2013/Countering-the-Problem-of-Falsified-and-Substandard-Drugs.aspx. Accessed 17 February 2013.

2. AttaranA, BarryD, BasheerS, BateR, BentonD, et al. (2012) How to achieve international action on falsified and substandard medicines. BMJ 345: e7381 Available: http://www.bmj.com/content/345/bmj.e7381. Accessed 19 February 2013.

3. JackA (2012) Faking it. BMJ 345: e7836.

4. BateR, JensenP, HessK, MooneyL, MilliganJ (2013) Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis. Int J Tuberc Lung Dis 17: 308–311 Available: http://www.aei.org/files/2013/02/05/-substandard-and-falsified-antituberculosis-drugs-a-preliminary-field-analysis_142125219328.pdf. Accessed 15 February 2013.

5. SinghS, BhutaniH, MariappanTT (2006) Quality problems of anti-tuberculosis fixed-dose combinations (FDCs): a way forward. Indian J Tuberc 53: 201–205.

6. LasersonKF, KenyonAS, KenyonTA, LayloffT, BinkinNJ (2001) Substandard tuberculosis drugs on the global market and their simple detection. Int J Tuberc Lung Dis 5: 448–454.

7. BateR, CoticelliP, TrenR, AttaranA (2008) Antimalarial drug quality in the most severely malarious parts of Africa—a six country study. PLoS ONE 3: e2132 doi:10.1371/journal.pone.0002132

8. BateR, MooneyL, HessK, MilliganJ, AttaranA (2012) Anti-infective medicine quality: analysis of basic product quality by approval status and country of manufacture. Res Rep Trop Med 3: 57–61 Available: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2138438. Accessed 20 February 2013.

9. BateR, HessK (2012) The role of pre-shipment batch testing in ensuring good medicine quality. Malaria World J 3: 11 Available: http://www.aei.org/files/2012/12/05/-bate-the-role-of-preshipment-batch-testing-in-ensuring-good-medicine-quality_12150071370.pdf. Accessed 18 February 2013.

10. Ministry of Health of Rwanda (2011) Guidelines for pharmacovigilance and medicine information system in Rwanda. Kigali: Ministry of Health of Rwanda. Available: http://spssms.msh.org/products/Rwanda_Pharmacovigilance%20Guidelines%20last%20draft%20version%2014%20June%202011.pdf. Accessed 20 February 2013.

11. FarmerPE, NuttCT, WagnerCM, SekabaragaC, NuthulagantiT, et al. (2013) Reduced premature mortality in Rwanda: lessons from success. BMJ 346: f65 Available: http://www.bmj.com/content/346/bmj.f65. Accessed 17 February 2013.

12. World Health Organization (2012) Global tuberculosis report 2012. Available: http://www.who.int/tb/publications/global_report/en/. Accessed 24 May 2013.

13. BinagwahoA, GasanaM, MucyoY, WagnerCM, NuttCT (2013) Resistant TB: use the tools available. Nature 494: 176 Available: http://www.nature.com/nature/journal/v494/n7436/full/494176a.html. Accessed 20 February 2013.

14. BinagwahoA, BateR (2013) Substandard drugs and the fight against TB: the challenge and the opportunity. Health Affairs Blog Available: http://healthaffairs.org/blog/2013/04/15/substandard-drugs-and-the-fight-against-tb-the-challenge-and-the-opportunity/. Accessed 15 April 2013.